Literature DB >> 12431788

Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell line.

Hideyasu Matsuda1, Kayoko Kinoshita, Akihiko Sumida, Koichi Takahashi, Shuichi Fukuen, Tsuyoshi Fukuda, Kyoko Takahashi, Isamu Yamamoto, Junichi Azuma.   

Abstract

Taurine is not only present in foods, tonics and nutrient drinks but is also used as a medicinal agent mainly for treatment of chronic heart failure and liver disease. However, little is known about its influence on drug-metabolizing enzymes, especially cytochrome P450 (CYP), in human. We examined whether taurine could affect the expression of CYP3A4 mRNA in the presence or absence of rifampicin (RFP), which is a potent inducer of CYPs, with HepG2 cells. Taurine enhanced twice the induction of CYP3A4 mRNA by RFP, but did not affect the expression by itself. This effect was both concentration- and time-dependent. On the other hand, taurine did not affect the induction by phenobarbital. Taurine did not increase intracellular uptake of RFP. Therefore, we conclude that taurine is an enhancer for the induction of CYP3A4 by RFP. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431788     DOI: 10.1016/s0167-4889(02)00345-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Carbonated soft drinks alter hepatic cytochrome P450 isoform expression in Wistar rats.

Authors:  Adel Alkhedaide; Mohamed Mohamed Soliman; Zein Shaban Ibrahim
Journal:  Biomed Rep       Date:  2016-09-26

2.  Rational deuteration of dronedarone attenuates its toxicity in human hepatic HepG2 cells.

Authors:  Lloyd Wei Tat Tang; Royden Yu Ren Lim; Gopalakrishnan Venkatesan; Eric Chun Yong Chan
Journal:  Toxicol Res (Camb)       Date:  2022-03-28       Impact factor: 2.680

Review 3.  Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor.

Authors:  Jiezhong Chen; Kenneth Raymond
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-02-15       Impact factor: 3.944

Review 4.  A Review of Daclatasvir Drug-Drug Interactions.

Authors:  Tushar Garimella; Xiaoli You; Reena Wang; Shu-Pang Huang; Hamza Kandoussi; Marc Bifano; Richard Bertz; Timothy Eley
Journal:  Adv Ther       Date:  2016-09-23       Impact factor: 3.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.